Blood test may predict Dementia's path

NCT ID NCT06529744

Recruiting now Knowledge-focused Sponsor: University Health Network, Toronto Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is looking for 500 people with early dementia or mild cognitive impairment to help develop a way to predict how their disease will progress. Researchers will use blood tests and other models to better understand each person's outlook. The goal is to give patients and doctors more confidence in planning for the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction Corticobasal Degeneration corticobasal syndrome dementia frontotemporal dementia Lewy body dementia Lewy Body Disease Parkinson disease primary progressive aphasia progressive supranuclear palsy vascular dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE CORTICOBASAL SYNDROME DEMENTIA DEMENTIA WITH LEWY BODIES FRONTOTEMPORAL DEMENTIA MILD COGNITIVE IMPAIRMENT PARKINSON DISEASE PRIMARY PROGRESSIVE APHASIA PROGRESSIVE SUPRANUCLEAR PALSY VASCULAR DEMENTIA

Contacts and locations

Locations

Baycrest
NOT_YET_RECRUITING

North York, Ontario, M6A 2E1, Canada
Centre for Addiction and Mental Health
NOT_YET_RECRUITING

Toronto, Ontario, M6J 1H1, Canada
Sunnybrook Health Sciences Centre
NOT_YET_RECRUITING

Toronto, Ontario, M4N 3M5, Canada
Toronto Western Hospital, University Health Network
RECRUITING

Toronto, Ontario, M5T 2S8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.